Data Driven Methods for Kinase Drug Design

webinar

Thu, 27 Apr 2023, 16:00 CEST (Berlin)

Prof. Dr. Andrea Volkamer, Saarland University, Germany

Data Driven Methods for Kinase Drug Design

Human protein kinases are involved in several diseases which turned them into an important class for targeted therapy. To date there are almost 6,000 kinase structures in the PDB and around 70 small molecule kinase inhibitors available. Still several challenges remain related to drug promiscuity, resistance, and untapped kinase territory.

In this BioSolveIT webinar, Andrea will summarize the portfolio of methods which either use the openly available kinase data to generate new knowledge, or enable the community to engage in this data more easily. Using the TeachOpenCADD platform, she will demonstrate how to orchestrate diverse CADD tasks for individual kinases. Furthermore, Andrea’s lab developed freely available tools supporting diverse tasks: (i) KinFragLib for fragment based kinase inhibitor design, (ii) KiSSim – a KLIFS-based kinase structural similarity fingerprint, and (iii) a pipeline to assess kinase similarity from different data perspectives. All examples make use of the OpenCADD-KLIFS module to facilitate the integration of KLIFS data into kinase research workflows.

Andrea will close with further ongoing projects in structure-informed ML for kinase polypharmacology (openkinome).

Join us for an exciting talk and a vivid discussion.

Current news

category
Events
Recordings of the BioSolveIT Day 2025 Available
October 15, 2025 13:39 CEST
Missed BioSolveIT Day 2025? The recordings from BioSolveIT Day 2025 are now live! Packed with practical insights for medicinal and computational chemists, the sessions showcase how SeeSAR, infiniSee, Chemical Space Docking®, and CoLibri accelerate real-world discovery, from pocket-aware design and HYDE-guided decisions to trillion-scale, synthesizable chemical space exploration and in-house...
Read on
Enamine’s REAL Space September 2025 Update - Now 83 Billion!
September 23, 2025 10:31 CEST
The September 2025 update of Enamine’s REAL Space brings a new expansion, now featuring over 83 billion accessible, drug-like products, up from 76 billion in the previous release. Built from 172 curated reactions and 192,487 reagents and building blocks based on in-house knowledge, this version further enhances one of the...
Read on
WuXi’s GalaXi Space September 2025 – Expanded to 26 Billion Molecules!
September 17, 2025 10:03 CEST
The September 2025 update of WuXi LabNetwork’s GalaXi Space delivers a major expansion, now featuring over 25.8 billion synthesis-ready products. Built from 185 curated reactions and 30,877 high-quality building blocks, GalaXi is one of the largest tangible Chemical Spaces for modern drug discovery. This release broadens structural diversity with novel...
Read on